Abiopharma

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders

Jiuzi Holdings Announces AI Intelligent Imaging Platform Achieves Milestone Progress and Advances Toward Commercial Deployment as Planned

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Osisko Development Announces Closings of Additional US$75 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes Bringing Total Offering to US$300 Million

Digital Turbine to Participate in the Roth 5th Annual Ad-Tech Summit and the 16th Annual Roth London Conference in June

BeOne Medicines établit une nouvelle référence en matière de contrôle à long terme de la LLC grâce aux données sur 78 mois concernant BRUKINSA présentées lors de l’ASCO 2026

Dividend in the amount of 28.136 agorot per share, record date: 9.6.26, payment 16.6.26

Alpha Cash Cardholders To Get $2.50 Back Monthly on Certain Transit in 11 U.S. Cities